Factor X antigen evaluation by means of a laser nephelometer in health and disease.

[1]  D. Connor,et al.  Progressive disseminated penicilliosis caused by Penicillium marneffei. Report of eight cases and differentiation of the causative organism from Histoplasma capsulatum. , 1985, American journal of clinical pathology.

[2]  A. Girolami,et al.  Excess of factor X antigen versus clotting counterpart in coumarin treated patients as determined by an Elisa method. , 1985, Folia haematologica.

[3]  A. Girolami,et al.  Prothrombin Evaluation as Obtained by Kinetics Studies of Antigen-Antibody Reaction in a Laser Nephelometer , 1984, Thrombosis and Haemostasis.

[4]  A. Girolami,et al.  The role of laser nephelometer in the study of abnormal clotting factors: characterization of two abnormal antithrombins (AT III Padua and AT III Padua2). , 1984, American journal of clinical pathology.

[5]  A. Girolami,et al.  Prothrombin antigen evaluation by means of laser nephelometry in health and disease. , 1982, American journal of clinical pathology.

[6]  A. Girolami,et al.  Chromogenic substrate (S-2238) prothrombin assay in prothrombin deficiencies and abnormalities. Lack of identity with clotting assays in congenital dysprothrombinemias. , 1980, American journal of clinical pathology.

[7]  J. T. ten Cate,et al.  Mechanized amidolytic technique for determination of factor X and factor-X antigen, and its application to patients being treated with oral anticoagulants. , 1980, Clinical chemistry.

[8]  A. Girolami,et al.  Factor X assays using chromogenic substrate S-2222. , 1980, American journal of clinical pathology.

[9]  T. Edgington,et al.  Combined functional and immunochemical analysis of normal and abnormal human factor X. , 1979, The Journal of clinical investigation.

[10]  G. Claeson,et al.  A new sensitive and highly specific chromogenic peptide substrate for factor Xa. , 1977, Thrombosis research.

[11]  K. Maxwell,et al.  Use of laser nephelometry in the measurement of serum proteins. , 1976, Clinical chemistry.

[12]  A. Girolami,et al.  Classical Factor X Deficiency , 1975 .

[13]  G. Buffone,et al.  Kinetics of the IgG-anti-IgG reaction, as evaluated by conventional and stopped-flow nephelometry. , 1974, Clinical chemistry.

[14]  A. Girolami,et al.  Crossover electrophoresis (electrosyneresis) visualization of the abnormal factor X (factor X Friuli). , 1972, The Journal of laboratory and clinical medicine.

[15]  K. Denson.  The Levels of Factors II, VII, IX and X by Antibody Neutralization Techniques in the Plasma of Patients Receiving Phenindione Therapy , 1971, British journal of haematology.

[16]  R. Scarpa,et al.  A ‘New’ Congenital Haemorrhagic Condition due to the Presence of an Abnormal Factor X (Factor X Friuli): Study of a Large Kindred , 1970, British journal of haematology.

[17]  C. Laurell,et al.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. , 1966, Analytical biochemistry.

[18]  K. Denson.  The specific assay of Prower-Stuart factor and factor VII. , 1961, Acta haematologica.

[19]  H. Schultze,et al.  Quantitative immunologische bestimmung von plasmaproteinen , 1959 .

[20]  F. Duckert,et al.  The Stuart-Prower Factor Assay and its Clinical Significance , 1958, Thrombosis and Haemostasis.